Assenagon Asset Management S.A.

Position in IRON — Disc Medicine, Inc.

CIK 1546007 SENNINGERBERG, N4

Position in IRON

as of Jun 30, 2026 · filed Aug 21, 2026 Compact

Position Value

$28,097,316

-$6,829,717 QoQ

Shares Held

384,158

-29.7% QoQ

Ownership

1.00%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#29

of 216 holders

Holding Since

Jun 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Assenagon Asset Management S.A. holds $1,940,218,245 across 69 Biotechnology names. IRON ranks #18 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	759,564	$377,298,225
2	ROIV	Roivant Sciences Ltd.	8,362,952	$295,964,871
3	REGN	Regeneron Pharmaceuticals, Inc.	244,927	$152,721,781
4	AXSM	Axsome Therapeutics, Inc.	454,682	$111,292,513
5	BMRN	Biomarin Pharmaceutical Inc	1,762,086	$100,826,560
6	HALO	Halozyme Therapeutics, Inc.	997,643	$78,085,517
7	MDGL	Madrigal Pharmaceuticals, Inc.	124,214	$66,696,707
8	TARS	Tarsus Pharmaceuticals, Inc.	947,495	$59,635,335

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$28,097,316	384,158	-29.7%	Shares	Sole	2026-08-21
2026-03-31	$34,927,033	546,247	+52.7%	Shares	Sole	2026-04-20
2025-12-31	$28,415,756	357,836	+3329.8%	Shares	Sole	2026-01-09
2025-09-30	$689,412	10,433	-85.9%	Shares	Sole	2025-10-07
2023-09-30	$3,484,224	74,164	-70.0%	Shares	Sole	2023-11-06
2023-06-30	$10,984,560	247,400	+300.3%	Shares	Sole	2023-07-25
2023-03-31	$1,309,647	61,805	-9.7%	Shares	Sole	2023-04-18
2022-12-31	$1,360,993	68,426	—	Shares	Sole	2023-01-12
2022-09-30 GMTX	—	82,171	+423.2%	Shares	Sole	2022-10-27
2022-06-30 GMTX	—	15,704	—	Shares	Sole	2022-07-27
No filing history on record for this holder in this stock.